Latest news with #DrugSupplyChainSecurityAct
Time Business News
22-05-2025
- Business
- Time Business News
Pharma Distributors and the Challenge of Counterfeit Drugs: Prevention and Solutions
Counterfeit drugs have become a grave concern in the pharmaceutical industry. They pose severe risks to patient safety and can undermine the trust in healthcare systems. Combating counterfeit drugs is a significant challenge for pharmaceutical wholesalers that require vigilance and advanced strategies. Read on to understand the various complexities associated with counterfeit drugs encountered by pharmaceutical wholesalers. The global nature of drug manufacturing and distribution makes it hard to track every product. Counterfeit drugs can slip into the supply chain at multiple points, which makes them difficult to detect. Oftentimes, pharmaceutical supply chains lack transparency. This opacity can create opportunities for counterfeiters to introduce fake products undetected. Medications in high demand and low supply are prime targets for counterfeiters. Hence, wholesalers need to be extra vigilant with these high-risk drugs. Here's how pharmaceutical wholesalers can prevent the counterfeit drug Implementing digital tracking systems, like blockchain technology, can enhance supply chain transparency. Tracking each drug package from manufacture to delivery can reduce the chances of counterfeits. Using tamper-evident packaging can help identify compromised products. Wholesalers should work with manufacturers to ensure all packaging includes anti-counterfeit measures. Collaborations and Data Sharing Collaborating with other stakeholders in the supply chain, including manufacturers, regulators, and pharmacies, can improve data sharing and collective vigilance against counterfeit drugs. Staying compliant with local and international regulations can help wholesalers monitor and prevent counterfeit drugs. Regular audits and inspections ensure all processes are up to standard. Drugzone, one of the top pharmaceutical distributors in the U.S., strictly follows the rules set by the Drug Supply Chain Security Act (DSCSA). This means they use advanced tracking technologies besides other measures to keep a close eye on every medication they distribute. Counterfeit drugs are fake medications that may contain incorrect or harmful ingredients. They pose serious risks to patient health and safety. TIME BUSINESS NEWS
Yahoo
14-05-2025
- Business
- Yahoo
Fusion Partners with MMCAP to Offer Advanced DSCSA Compliance Solution, Fusion360, to Government Healthcare Facilities Nationwide
WOODBRIDGE, N.J., May 13, 2025 /PRNewswire/ -- Fusion Health, a leading provider of health technology solutions for public health settings, today announced a new agreement with MMCAP, a national cooperative purchasing organization. This partnership will provide MMCAP members streamlined access to, and negotiated pricing for, Fusion360—Fusion Health's comprehensive DSCSA (Drug Supply Chain Security Act) compliance management solution. Through this agreement, MMCAP's extensive network of over 26,000 members—spanning state agencies, counties, cities, and school districts across all 50 states—will have streamlined access to Fusion360. This powerful software solution is designed to help pharmacies and healthcare systems efficiently meet federal DSCSA requirements, enhance pharmaceutical supply chain integrity, and ensure patient safety by simplifying traceability, verification, and reporting processes for prescription medications. "We are thrilled to collaborate with MMCAP and empower their members with Fusion360, our leading-edge DSCSA compliance solution," said Michael Jakovcic, CRO, Fusion. "This partnership underscores our commitment to providing pharmacies across the country with the critical tools they need for operational excellence." Fusion360 helps organizations automate DSCSA compliance tasks, reduce the risk of counterfeit or illegitimate products entering the supply chain, and maintain audit-readiness. This ensures that MMCAP members can confidently manage their pharmaceutical operations while focusing on patient care. Fusion360 is a key component of Fusion's broader mission to support these essential organizations. Beyond DSCSA compliance, Fusion Health offers a comprehensive suite of integrated solutions, including our robust electronic health record platform (FusionEHR), specialized 340B management software, comprehensive retail and inpatient pharmacy management systems, and our innovative Fusion Financials solution designed to streamline revenue cycle management and billing services. Together, these offerings help our partners enhance care delivery, improve efficiency, and navigate complex regulatory landscapes. Learn more about Fusion Health's solutions for government and public health facilities at About Fusion Health Fusion Health equips providers in public safety agencies, behavioral health settings, educational institutions, and other governmental organizations with an ecosystem of solutions they can use to work faster, smarter, and more efficiently to deliver highly effective care to patients. We offer a portfolio of innovative, market-leading healthtech products that assist clinicians in making care decisions and aid organizations in managing the health of their populations. Fusion Health's clinical technologies connect people with information systems at thousands of facilities nationwide, driven by a vision of a future where our products contribute to a ripple effect of positive change within the broader public health landscape—a landscape where every individual, regardless of circumstance, has access to quality care. Learn more at Media Contact: Jerry Kimbrough, View original content to download multimedia: SOURCE Fusion Health
Yahoo
13-05-2025
- Business
- Yahoo
Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
CHICAGO, May 13, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Market is projected to be valued at US$ 139.2 billion in 2024 and reach USD 251.6 billion by 2034, growing at a CAGR of 6.1% according to a new report by The Research Insights. The market for pharmaceutical packaging is driven by the rising demand for adoption of branded and generic medicines in emerging economies across the globe which have propelled the demand for its packaging. Market Overview and Growth Trajectory: Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034. For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness. E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality. Stay Updated on The Latest Pharmaceutical Packaging Market Trends: Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs. Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India. Pharmaceutical Packaging Market Segmentation and Geographical Insights: Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024. Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024. Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024. Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024. The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: Key Players and Competitive Landscape: The Pharmaceutical Packaging Market is characterized by the presence of several major players, including: Gerresheimer AG Schott AG Owens Illinois, Inc. Amcor plc Becton, Dickinson, and Company AptarGroup, Inc. West Pharmaceutical Services, Inc. Ardagh Group S.A. Smurfit WestRock Comar, LLC CCL Industries, Inc. Vetter Pharma International SGD Pharma Bormioli Pharma S.p.A. Klöckner Pentaplast These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. For Region-Specific Market Data, Check Out Brief Sample Pages: Pharmaceutical Packaging Market Recent Developments and Innovations: In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics. In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management. In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET. Conclusion: The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape. Related Report Titles: Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Vials And Ampoules Market Size, Share & Trends Analysis Report Small Volume Parenteral Market Size, Share & Trends Analysis Report About Us: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1 312-313-8080Website: Logo: View original content: SOURCE The Research Insights
Yahoo
13-05-2025
- Business
- Yahoo
Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
CHICAGO, May 13, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Market is projected to be valued at US$ 139.2 billion in 2024 and reach USD 251.6 billion by 2034, growing at a CAGR of 6.1% according to a new report by The Research Insights. The market for pharmaceutical packaging is driven by the rising demand for adoption of branded and generic medicines in emerging economies across the globe which have propelled the demand for its packaging. Market Overview and Growth Trajectory: Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034. For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness. E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality. Stay Updated on The Latest Pharmaceutical Packaging Market Trends: Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs. Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India. Pharmaceutical Packaging Market Segmentation and Geographical Insights: Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024. Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024. Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024. Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024. The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: Key Players and Competitive Landscape: The Pharmaceutical Packaging Market is characterized by the presence of several major players, including: Gerresheimer AG Schott AG Owens Illinois, Inc. Amcor plc Becton, Dickinson, and Company AptarGroup, Inc. West Pharmaceutical Services, Inc. Ardagh Group S.A. Smurfit WestRock Comar, LLC CCL Industries, Inc. Vetter Pharma International SGD Pharma Bormioli Pharma S.p.A. Klöckner Pentaplast These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. For Region-Specific Market Data, Check Out Brief Sample Pages: Pharmaceutical Packaging Market Recent Developments and Innovations: In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics. In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management. In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET. Conclusion: The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape. Related Report Titles: Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Vials And Ampoules Market Size, Share & Trends Analysis Report Small Volume Parenteral Market Size, Share & Trends Analysis Report About Us: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1 312-313-8080Website: Logo: View original content: SOURCE The Research Insights Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-04-2025
- Business
- Yahoo
MMCAP Infuse Expands Inmar Agreement, Deploying OneRecall® for Smarter Recalls
MMCAP Infuse members gain automated tools to meet DSCSA requirements and safeguard patient safety WINSTON-SALEM, N.C., April 9, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare logistics and compliance solutions, has announced the renewal and expansion of its contract with MMCAP Infuse through a multi-year agreement. This renewed contract extends access to Inmar's comprehensive healthcare solutions while introducing OneRecall®, an advanced recall management system designed to streamline workflows and reduce alert fatigue for healthcare providers. As a national cooperative group purchasing organization (GPO), MMCAP Infuse supports over 34,500 member facilities, including state agencies, counties, cities, school districts, public health facilities, and educational institutions. GPOs like MMCAP Infuse play a critical role in helping their members navigate complex regulatory landscapes, including compliance with the Drug Supply Chain Security Act (DSCSA). However, ensuring full compliance presents operational and logistical challenges, such as standardizing product tracking, managing large networks of suppliers, and implementing efficient recall protocols. With the expansion of this partnership, MMCAP Infuse members will now have direct access to OneRecall®, a solution designed to help address these challenges and enhance regulatory adherence. Beyond recall management, Inmar has long provided MMCAP Infuse with a suite of healthcare solutions that enhance operational efficiency, regulatory compliance, and patient safety across its diverse membership. From pharmaceutical returns management to supply chain visibility tools, Inmar helps MMCAP Infuse members reduce waste, optimize inventory, and ensure compliance with evolving industry regulations. With this contract renewal, MMCAP Infuse members continue to benefit from Inmar's expertise in streamlining purchasing processes, automating compliance workflows, and enhancing financial and operational transparency. With MMCAP Infuse members preparing for full DSCSA implementation, ensuring compliance while managing complex recall processes is a top priority. Under the renewed agreement, Inmar's OneRecall® solution will help MMCAP Infuse members meet DSCSA requirements by automating recall notifications, reducing manual tracking, and minimizing administrative burdens. OneRecall® enables members to prioritize high-risk recalls, respond quickly, and maintain regulatory compliance without disrupting patient care. Beyond DSCSA compliance, MMCAP Infuse must support a diverse network of government healthcare facilities while maintaining operational efficiency. Managing large-scale purchasing agreements across thousands of member sites requires seamless coordination, real-time data tracking, and proactive compliance support. Inmar's long-standing agreement with MMCAP Infuse provides integrated solutions that simplify these processes, offering advanced tools for recall management, regulatory reporting, and inventory optimization. The expansion of OneRecall® further enhances MMCAP Infuse members' ability to improve data accuracy, reduce administrative overhead, and strengthen compliance training. "This expanded agreement reinforces our commitment to equipping MMCAP Infuse members with the tools they need to remain compliant, operate efficiently, and focus on delivering quality healthcare," said Brian Nightengale, EVP, Healthcare at Inmar Intelligence. "By integrating OneRecall® into their workflow, we are not only improving recall responsiveness but also supporting broader supply chain security initiatives." About Inmar IntelligenceThrough curiosity and the intelligent use of data and technology, we optimize the healthcare value chain to improve patient safety, access and affordability. As a partner for over 40 years to health systems, pharmacies and life sciences companies, we design and build solutions to address the complex challenges in the business of healthcare. Our mission is to enable improved financial and patient outcomes to meet the evolving needs of the healthcare industry. Visit and follow us on LinkedIn. Email us at solutions@ or call (866) 440-6917. Media Contact: Lari Harding, Senior Vice President Healthcare Industry Affairs & Strategic Partnerships Email: press@ View original content to download multimedia: SOURCE Inmar Intelligence Sign in to access your portfolio
